- Disease: Post-COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Prospective, Single centre
- Objective: To assess symptom outcome and functional ability in 20 patients with post COVID syndrome meeting myalgic encephalomyelitis/chronic fatigue syndrome diagnostic criteria with elevated ß2R antibodies undergoing antibody depletion by immunoadsorption
- Number of participants enrolled: 20
- Study enrolling from to
- Study includes follow-up for 1 year
- Standardisation: ICD-10
Study Data
- Adults (18-64 years)
- General population
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Immunoadsorption
External Links
Other information
Funders/Sponsors:
- BMBF (01EP2201) – Federal Ministry of Education and Research
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to